These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 27542228)
1. MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox state. Frottin F; Bienvenut WV; Bignon J; Jacquet E; Vaca Jacome AS; Van Dorsselaer A; Cianferani S; Carapito C; Meinnel T; Giglione C Oncotarget; 2016 Sep; 7(39):63306-63323. PubMed ID: 27542228 [TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases. Wang J; Lou P; Henkin J J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954 [TBL] [Abstract][Full Text] [Related]
3. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943 [TBL] [Abstract][Full Text] [Related]
4. Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers. Shimizu H; Yamagishi S; Chiba H; Ghazizadeh M Adv Clin Exp Med; 2016; 25(1):117-28. PubMed ID: 26935506 [TBL] [Abstract][Full Text] [Related]
5. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity. Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773 [TBL] [Abstract][Full Text] [Related]
6. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930 [TBL] [Abstract][Full Text] [Related]
7. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression. Hu X; Addlagatta A; Lu J; Matthews BW; Liu JO Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18148-53. PubMed ID: 17114291 [TBL] [Abstract][Full Text] [Related]
8. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides. Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity. Cornelius P; Mayes BA; Petersen JS; Turnquist DJ; Dufour PJ; Dannenberg AJ; Shanahan JM; Carver BJ Mol Cancer Ther; 2024 May; 23(5):595-605. PubMed ID: 38530115 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of a cellular stable and detectable biotinylated fumagillin probe and investigation of cell permeability of fumagillin and its analogs to endothelial and cancer cells. Zhou GC; Liu F; Wan J; Wang J; Wang D; Wei P; Ouyang P Eur J Med Chem; 2013; 70():631-9. PubMed ID: 24211639 [TBL] [Abstract][Full Text] [Related]
11. Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats. Kass DJ; Rattigan E; Kahloon R; Loh K; Yu L; Savir A; Markowski M; Saqi A; Rajkumar R; Ahmad F; Champion HC PLoS One; 2012; 7(4):e35388. PubMed ID: 22509410 [TBL] [Abstract][Full Text] [Related]
12. Methionine aminopeptidase 2 is required for HSC initiation and proliferation. Ma AC; Fung TK; Lin RH; Chung MI; Yang D; Ekker SC; Leung AY Blood; 2011 Nov; 118(20):5448-57. PubMed ID: 21937698 [TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784 [TBL] [Abstract][Full Text] [Related]
14. Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies. Weako J; Uba AI; Keskin Ö; Gürsoy A; Yelekçi K Comput Biol Chem; 2020 Jun; 86():107244. PubMed ID: 32252002 [TBL] [Abstract][Full Text] [Related]
15. Omics Assisted N-terminal Proteoform and Protein Expression Profiling On Methionine Aminopeptidase 1 (MetAP1) Deletion. Jonckheere V; Fijałkowska D; Van Damme P Mol Cell Proteomics; 2018 Apr; 17(4):694-708. PubMed ID: 29317475 [TBL] [Abstract][Full Text] [Related]
16. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. Endo H; Takenaga K; Kanno T; Satoh H; Mori S J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292 [TBL] [Abstract][Full Text] [Related]
17. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo. Lu J; Chong CR; Hu X; Liu JO J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390 [TBL] [Abstract][Full Text] [Related]
18. Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470. Alvarado JJ; Nemkal A; Sauder JM; Russell M; Akiyoshi DE; Shi W; Almo SC; Weiss LM Mol Biochem Parasitol; 2009 Dec; 168(2):158-67. PubMed ID: 19660503 [TBL] [Abstract][Full Text] [Related]
19. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo. Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010 [TBL] [Abstract][Full Text] [Related]
20. The specificity in vivo of two distinct methionine aminopeptidases in Saccharomyces cerevisiae. Chen S; Vetro JA; Chang YH Arch Biochem Biophys; 2002 Feb; 398(1):87-93. PubMed ID: 11811952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]